Literature DB >> 7938115

Differentiation of intracranial morphine self-administration behavior among five brain regions in mice.

V David1, P Cazala.   

Abstract

BALB/c mice were unilaterally implanted with a guide cannula, the tip of which was positioned 1.5 mm above either the lateral hypothalamus (LH) the medial hypothalamus (MH), the mesencephalic central gray area (CG), or either the dorsal (DRF) or ventral parts (VRF) of the reticular formation. On each day of the experimental period a stainless steel injection cannula was inserted into these brain structures to compare the self-administration of two doses of morphine (5 ng or 50 ng), using a spatial discrimination task in a Y-maze. At the dose of 5 ng, LH-, MH-, CG-, and VRF-injected mice all showed a regular self-administration response. At the dose of 50 ng, a discrimination between the reinforced arm and the neutral arm of the Y-maze was observed in LH-, MH-, and VRF-injected mice. Animals of the MH group exhibited the highest level of discrimination performance. At this dose, long injection latencies (> 15 min) were recorded in the CG group, which constrained us to reduce the number of daily trials from 10 to 4. In these modified conditions, CG animals clearly self-injected the dose of 50 ng of morphine. Subcutaneous injections of naloxone (4 mg/kg) reduced the number of self-administrations of morphine at each of the four responding structures. Marked signs of physical dependence (escape attempts) were observed in the four groups but with a higher frequency in CG and MH animals. When the injections of naloxone were suspended, a regular self-administration reappeared.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938115     DOI: 10.1016/0091-3057(94)90324-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  10 in total

1.  Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

Authors:  M Besson; V David; S Suarez; A Cormier; P Cazala; J-P Changeux; S Granon
Journal:  Psychopharmacology (Berl)       Date:  2006-06-03       Impact factor: 4.530

Review 2.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

Review 3.  Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory.

Authors:  Satoshi Ikemoto
Journal:  Neurosci Biobehav Rev       Date:  2010-02-10       Impact factor: 8.989

4.  Norepinephrine and serotonin receptors in the paraventricular nucleus interactively modulate ethanol consumption.

Authors:  C W Hodge; C J Slawecki; A S Aiken
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

5.  Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area.

Authors:  B Bontempi; F R Sharp
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

Review 6.  Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.

Authors:  Chloe J Jordan; Jianjing Cao; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-19       Impact factor: 5.250

Review 7.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

8.  Periaqueductal gray afferents synapse onto dopamine and GABA neurons in the rat ventral tegmental area.

Authors:  Natalia Omelchenko; Susan R Sesack
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

Review 9.  Neurocircuitry of drug reward.

Authors:  Satoshi Ikemoto; Antonello Bonci
Journal:  Neuropharmacology       Date:  2013-05-07       Impact factor: 5.250

Review 10.  Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review.

Authors:  Shane W Kaski; Allison N White; Joshua D Gross; David P Siderovski
Journal:  Anesth Analg       Date:  2021-02-01       Impact factor: 6.627

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.